Midgard Science

Labs / ADME, DMPK & toxicology

SciRhom GmbH

Martinsried, Germany · scirhom.com

On your own

Free. Their own form.

Contact SciRhom GmbH directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

SciRhom GmbH develops iRhom2-targeting antibody therapies for autoimmune diseases and related indications. It is based in Munich, Germany, and is advancing its lead program SR-878 through clinical development. The company works on the TACE/ADAM17 pathway and has collaborated with the Medical University of Vienna and Prof. Carl Blobel of the Hospital for Special Surgery in New York City.

They take quote requests by email.

What they offer

  • iRhom2-targeting therapeutic development

    Develops proprietary and first-in-class iRhom2-targeting therapies for autoimmune diseases and other indications.

  • Therapeutic antibody development

    Develops humanized antibodies against iRhom2 with the aim of modulating TACE/ADAM17-controlled inflammatory pathways.

  • Clinical study execution for SR-878

    Conducts a first-in-human, double-blind, placebo-controlled, single ascending dose study of SR-878 in healthy volunteers.

What they work on

Modalities
Small molecule, Antibody
Species and models
mouse models of rheumatoid arthritis, mouse models of inflammatory bowel disease, healthy volunteers
Scale and capacity
up to 48 healthy volunteers
Therapeutic areas
autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, lupus nephritis
Turnaround
study expected to read out in H2 2025
Sites
Munich, Germany · Vienna, Austria · New York City, USA
Serves
Germany, Austria, USA
Founded
2016

Similar labs. Bioklone Biotech Private Limited, Oncodesign Services, Sparx BIO, Veloxity Labs

Found in a contract services directory. Listing built from scirhom.com. Work here? Claim this listing.

SciRhom GmbH · Midgard Science